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Abstract 
Background: Structural alterations may correlate with symptom severity in psychotic disorders, 
but the existing literature on this issue is heterogeneous. Additionally, it is not known how 
cortical thickness and cortical surface area correlate with symptom dimensions of psychosis. 
Methods: Subjects included 455 individuals with schizophrenia, schizoaffective, or bipolar I 
disorders. Data were obtained as part of the Bipolar Schizophrenia Network for Intermediate 
Phenotypes (BSNIP) study. Diagnosis was made through the Structured Clinical Interview for 
DSM-IV. Positive and negative symptom subscales were assessed using the Positive and 
Negative Syndrome Scale (PANSS). Structural brain measurements were extracted from T1-
weight structural MRIs using FreeSurfer v5.1 and were correlated with symptom subscales using 
partial correlations. Exploratory factor analysis was also used to identify factors among those 
regions correlating with symptom subscales. 
Results: The positive symptom subscale correlated inversely with gray matter volume (GMV) 
and cortical thickness in frontal and temporal regions, while the negative symptom subscale 
correlated inversely with right frontal cortical surface area. Among regions correlating with the 
positive subscale, factor analysis identified four factors, including a temporal cortical thickness 
factor and frontal GMV factor. Among regions correlating with the negative subscale, factor 
analysis identified a frontal GMV-cortical surface area factor. There were no significant 
diagnosis by structure interactions with symptom severity. 
Conclusion: Structural measures correlate with positive and negative symptom severity in 
psychotic disorders. Cortical thickness demonstrated more associations with psychopathology 
than cortical surface area. 
Keywords: positive, negative, cortical thickness, surface area, psychopathology, gray matter
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Introduction 
Structural imaging studies have established the presence of subtle structural brain 
alterations in psychotic disorders. For schizophrenia, some of the most consistent findings 
include reductions in gray matter volume (GMV) of frontal, temporal, and limbic regions 
1
, while 
bipolar disorder has also been associated with GMV reductions in prefrontal, temporal, and 
limbic regions 
2,3
.  
Studies have found correlations between structural alterations and symptom dimensions 
of psychosis; however, findings have been heterogeneous. In schizophrenia, inverse correlations 
between positive symptom severity and GMV of temporal lobe regions, most commonly the 
superior temporal gyrus (STG), have been frequently reported 
4-8
, but a minority of studies have 
observed no correlation or a direct correlation between positive symptom severity and GMV of 
these regions 
9-11
. Results have been similarly mixed for the negative symptom dimension, with 
several studies finding inverse correlations with GMV of frontal regions 
12-14
, and other studies 
reporting no correlation or a positive correlation with frontal regions 
15-17
.   
Multiple reasons may account for the heterogeneity in findings. Positive symptoms of 
psychosis can wax and wane with time; thus results may be influenced by illness acuity of 
subjects at the time of scan. Other reasons for heterogeneity of results may include variations in 
technical aspects of imaging methodology, variable adjustment for confounding factors, and 
differences in subject characteristics, such as duration of illness.  
In addition to the heterogeneity of findings on clinical correlations with GMV, the 
literature is limited regarding correlations with non-volumetric structural measures.  Two 
constituents of volume, cortical thickness (CT) and cortical surface area (CSA), have 
Page 4 of 31
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4 
 
demonstrated significant alterations in both schizophrenia 
18-20
 and bipolar disorder 
21-23
. They 
may correlate differently with psychopathology due to their distinct neurobiological and genetic 
origins. According to a prevailing theory of cortical development, CSA is determined by the total 
number of cortical columns that form the cerebral cortex, while CT is determined by number of 
neurons within each column 
24-26
. A recent longitudinal neuroimaging study of children found 
evidence for independent developmental trajectories of CT and CSA 
27
. Additionally, 
neuroimaging studies of twins have found that CSA and CT are both highly heritable but 
probably genetically distinct 
28
. 
Thus far, the literature has not established whether CT and CSA have distinct correlations 
with positive and negative symptoms. Correlations have been reported between CT and 
propensity for hallucinations 
19
 and positive symptoms 
29
 among individuals with schizophrenia. 
However, one cross-diagnostic study of psychosis did not find an association between CT and 
symptom dimensions of psychosis 
22
. Analysis of symptom correlations with CT and CSA may 
reveal their differential contributions to psychopathology, which in turn could help identify more 
specific neuropathological processes that drive the emergence of psychotic symptoms. In 
addition, inclusion of multiple diagnostic categories may reveal whether symptom-structure 
correlations are trans-diagnostic. 
In this study, we examined correlations between symptom dimensions of psychosis and 
regional GMV, CSA and CT in schizophrenia, schizoaffective disorder and bipolar I disorder 
with psychosis. Correlations were examined using partial correlations between individual regions 
and subscales, and factor analysis was used to summarize overall structure-symptom 
relationships. Based on the existing literature 
30
, we hypothesized that temporal alterations would 
correlate with the positive subscale, while frontal alterations would correlate with the negative 
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subscale. We also hypothesized that CT and CSA would show distinct correlations with symptom 
dimensions. This is one of the largest sample sizes to date in which associations with dimensions 
of psychosis have been examined. 
 
Methods 
Participants 
Subjects included individuals with a DSM-IV diagnosis of schizophrenia, schizoaffective 
disorder, or bipolar I disorder with psychotic features. Subjects were recruited as part of the 
Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP), using recruitment 
methods that have been detailed elsewhere 
31,32
. Inclusion criteria included the following: (1) age 
15 – 65; (2) English proficiency, as determined by ability to follow task instructions; (3) no 
known history of neurologic disorders including head injury; (4) no history of substance abuse 
within the last month or substance dependence within the last 6 months; and (5) negative urine 
toxicology screen on day of testing. Patients were generally clinically stable and receiving 
consistent psychopharmacological treatment for 4 weeks prior to testing. Study protocols were 
approved by institutional review boards at each study site, and subjects signed informed consent 
forms. 
All subjects received the Structured Clinical Interview for DSM-IV (SCID-IV) 
33
. A 
consensus process was used to establish diagnosis using results from the SCID-IV, chart review, 
and review of psychiatric and medical histories. The Positive and Negative Symptom Scale 
(PANSS) 
34
 was used to assess positive, negative, and general symptoms in patients. Inter-site 
standardization of symptom ratings was carried out by periodic meetings for rater training, using 
established ‘gold standard’ interviews. At the beginning of the study, there was a face-to-face 
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training session for all raters, with a requirement for reliability of >0.85. Rater training was 
repeated annually to re-establish reliability 
31
.  
A total of 455 patients had complete datasets available for structural MRI and symptom 
scales for analysis of structure-symptom correlations 
31,32
. Of these 455 subjects, 181 individuals 
were categorized as having schizophrenia, 117 individuals as having schizoaffective disorder, 
and 157 individuals as having bipolar I disorder with psychotic features. 352 healthy controls 
were also evaluated in the larger study; they received structural MRIs but did not receive PANSS 
assessments. 
 
MRI-structural imaging  
High-resolution isotropic T1-weighted MPRAGE sequences were obtained. Sites used 
comparable but slightly different MPRAGE acquisition parameters; full details for each site have 
been described previously 
31
. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) protocol 
was used at all sites to standardize imaging analysis (http://www.loni.ucla.edu/ADNI). All 
images were subjected to a rigorous data quality control process. First, images were opened, 
converted to nifti format, and checked for scanner artifacts. If the images passed through this 
check, they were run through auto-recon 1 in FreeSurfer v5.1 
35
. Images were then checked for 
remaining non-brain tissues (dura or sinus). Trained raters, all reliable above 95%, edited images 
to remove any remaining non-brain tissue. An independent rater then determined if images were 
adequately cleaned for segmentation, and images were then processed through auto-recon 2 and 
3. Freesurfer v5.1 software was used to extract regional GMV, CT and CSA measurements.  
 
Statistical Analysis 
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All statistical analysis was done using the program R (Vienna, Austria; 2013, 
http://www.R-project.org, version 2.15.3). Data were examined for bivariate normality using the 
multivariate Shapiro-Wilk test (R package: mvnormtest), revealing that clinical symptom 
measures were not normally distributed. Non-parametric tests were used for further analyses. 
Diagnostic differences in demographic variables and symptom subscales were tested through the 
Kruskal-Wallis and chi-squared tests. Partial correlations were performed to correlate individual 
structural measures with symptom subscales. Additionally, a factor analysis approach was used 
to identify structural factors among regions associated with symptom subscales. 
 
Partial correlations between structural measures and symptom subscales 
A series of variables were tested for potential inclusion as co-variates. These included 
age, sex, race, study site, intracranial volume (ICV), socioeconomic status, patient educational 
level, duration of illness, and antipsychotic medication status (a binary variable representing 
whether or not the patient was currently on an antipsychotic). Duration of illness was computed 
by subtracting age at illness onset from current age. Socioeconomic status was represented by 
patient Hollingshead Index score, while patient educational level was represented by patient 
years of education. Study site was treated as a categorical variable, with each site being ‘dummy 
coded’ as a binary variable for regression analyses. Variables were retained as co-variates if they 
correlated with either structural measures or symptom subscales, using the Kruskal-Wallis test 
for categorical variables and the Spearman correlation for continuous variables.  
Using partial Spearman correlations, symptom subscales were first correlated with GMV, 
CSA, and mean CT of each lobe, and were Hochberg-adjusted for multiple comparisons (32 
comparisons per subscale) 
36
. For each lobe that demonstrated statistically significant 
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correlations with a symptom subscale, sub-regions of that lobe were then correlated with that 
symptom subscale in a step-down fashion (see Supplemental Table 1 for lists of the sub-regions 
that constituted each lobe). These correlations were again Hochberg-adjusted for multiple 
comparisons by the total number of sub-regions tested for correlations with that symptom 
subscale.  
GMV and CSA for each lobe were computed by adding the GMVs or CSAs of 
component sub-regions. A mean CT for each lobe was determined by calculating a weighted 
average of the cortical thicknesses of component sub-regions (i.e., CT of each sub-region 
multiplied by CSA of that sub-region, divided by total CSA for that lobe).  
Lobes and sub-regions that showed significant correlations in the whole-group analysis 
were then tested for correlations with symptom subscales within each diagnostic group, and were 
corrected for total number of correlations tested within that diagnostic group. Symptom 
subscales and PANSS total scores were also correlated with total GMV. Finally, a supplemental 
analysis was done using current antipsychotic dose in chlorpromazine equivalents, which was 
only available for 295 out of 455 patients. Analyses were repeated in this subset of patients with 
and without chlorpromazine dose as a co-variate to evaluate the impact of this co-variate. 
 
Exploratory factor analysis 
 To construct an enriched sample of brain regions, all regional structural measures (80 
GMV measures, 66 CSA measures, and 66 CT measures) were first screened for correlations 
with the positive and negative symptom subscales. Regional measures that correlated with the 
positive subscale at a significance level of p < 0.05, uncorrected, were entered into factor 
analysis. These regional measures were regressed against age, ICV, sex, and race. The residuals 
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of these regressions were then used to create the correlation matrix for factor analysis, as has 
been done with structural brain measures previously 
37,38
; that is, the correlation matrix for factor 
analysis consisted of partial correlations among these regional measures, controlling for co-
variates of age, ICV, sex, and race.  
Principal factor extraction (also called ‘principal axes factoring’) was used to extract 
factors because of deviations from multivariate normality 
39
. A scree test was performed to obtain 
an initial estimate of number of factors 
40,41
. Additionally, several factor analyses were performed 
using different numbers of factors and were evaluated for overall factor structure. A final number 
of factors was chosen if it produced factors with no or few item cross-loadings and at least three 
variable loadings above 0.45 
42
.  Direct oblique rotation was performed to assess if factors were 
correlated with each other. Factor scores for subjects were derived using regression to maximize 
determinacy of scores 
43
.   
Each factor score was entered as a predictor into a regression model with a full set of co-
variates (see previous section) to verify associations with the positive symptom subscale. Next, 
all factor scores were entered into a single model with co-variates to assess their relative 
correlations with symptom subscale scores. To assess specificity of correlations between factor 
scores and symptom subscales, factor scores were also tested for correlations with the negative 
subscale. Finally, to assess diagnosis by structure interactions, models were re-run with the 
inclusion of diagnosis and diagnosis by structure interaction terms. Assumptions of multiple 
regression were tested through visualization of QQ plots and residual-versus-fitted plots. 
An identical and separate factor analysis process was performed using those regions that 
correlated with the negative symptom subscale.   
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Results 
Demographics  
Subject demographics and study site demographics are presented in Table 1 and 
Supplemental Table 2, respectively. Mean values for symptom subscales varied across diagnostic 
groups and study sites (p < 0.05 using Kruskal-Wallis rank sum test).  Post-hoc comparisons of 
symptom subscales in schizophrenia and bipolar I disorder indicated that all symptom subscales 
were significantly higher in the schizophrenia group (p < 0.05 using Wilcoxon rank sum test). 
[Table 1] 
Partial correlations between structural measures and symptom subscales 
All potential co-variates demonstrated correlations with at least one symptom subscale 
and were retained as co-variates in further analyses. Additionally, age, sex, race, study site, 
duration of illness, and intracranial volume correlated with structural measures (p-adjusted < 
0.05).  
Correlations with structural measures in combined group. PANSS positive symptom 
subscale was correlated with frontal and temporal GMV reductions and temporal CT reductions, 
while the PANSS negative subscale was correlated with reductions in right frontal CSA (p-
adjusted < 0.05, Table 2, Figure 1, Supplemental Figure 1). There were no correlations with the 
PANSS general subscale.   
[Table 2] 
Correlations with structural measures within diagnostic groups. These structural 
measures were then evaluated for symptom-subscale correlations within diagnostic groups. 
Correlations remained significant within the schizophrenia group, but only the correlation with 
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the right insula CT would have survived correction for multiple comparisons. Correlations within 
bipolar disorder and schizoaffective disorder were largely non-significant (Table 2).  
Correlations with total GMV. In the combined group of all patients, total GMV 
correlated inversely with the PANSS positive subscale (r = -0.177, p = 0.00015) and the PANSS 
total score (r  = -0.118, p = 0.011), but not with the PANSS negative subscale (r = -0.061, p = 
0.19) or the PANSS general subscale (r = -0.0827, p = 0.08).   
Among subjects with available data on antipsychotic dose in chlorpromazine equivalents, 
effect sizes of correlations decreased when chlorpromazine equivalent medication dose was 
included as a co-variate, but the overall pattern of correlations was very similar. 
 [Figure 1] 
 Exploratory Factor Analysis 
 Positive symptom subscale. Initial screening revealed that 58 out of 212 regions were 
correlated with the positive subscale (p < 0.05, uncorrected). Scree test suggested between 4 and 
6 factors, and further evaluation supported four reliable factors: a temporal CT factor, a frontal 
GMV factor, a fronto-parietal CT factor, and a precuneus GMV-SA factor (Table 3, Supplemental 
Table 3). There were no cross-loadings of variables. Direct oblique rotation was retained because 
factors were correlated.  
[Table 3] 
 All four factor scores were significant predictors of the positive subscale in separate 
regression models with co-variates (temporal CT score: B = -1.04, p = 0.00035; frontal GMV 
score: B = -1.16, p = 0.000047; fronto-parietal CT score: B  = -0.66, p = 0.024; precuneus GMV-
SA score: B = -1.0, p = 0.00071). When all four factor scores were entered into the same 
regression model with co-variates, the temporal CT score (B = -0.80, p = 0.028) and frontal 
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GMV score (B = -0.71, p = 0.032) remained significant predictors of the positive subscale 
(adjusted R
2
 = 0.176). There were no significant diagnosis by factor interactions. None of the 
factor scores were significant predictors of the negative subscale. 
 Negative symptom subscale. Fourteen out of 212 regions correlated with the negative 
subscale upon initial screen (p < 0.05, uncorrected). Scree test suggested one factor, and 
extraction of more than one factor led to degenerate factor structure and cross-loading of 
variables. Further evaluation supported a frontal GMV-SA factor (Table 3, Supplemental Table 
4). No rotation was performed because of the single factor structure. This factor score was a 
significant predictor of the negative subscale (B = -0.99, p = 0.00032, adjusted R
2
 = 0.139). The 
diagnosis by factor interaction was not significant. Lastly, this factor was a significant predictor 
of the positive subscale (B = -0.87, p = 0.0019, adjusted R
2
 = 0.150). 
   
Discussion 
This study examined correlations between symptom dimensions and regional GMV, CT, 
and CSA, in a group of individuals with schizophrenia, schizoaffective disorder, or bipolar I 
disorder with psychotic features. Partial correlations were used to evaluate symptom correlations 
with individual regions, and factor analysis was used to summarize and compare structure-
symptom relationships. The PANSS positive subscale correlated with reductions in both temporal 
and frontal structural measures. Among regions correlating with the positive subscale, factor 
analysis identified a temporal CT factor, a frontal GMV factor, a fronto-parietal CT factor, and a 
precuneus GMV-SA factor, of which the temporal CT and frontal GMV factors independently 
predicted positive symptom severity when all four factors were jointly entered in a regression 
model. 
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Temporal regions have been previously implicated in the production of psychotic 
symptoms. Functional MRI studies have noted activation of temporal regions during real-time 
auditory hallucinations 
44
, while structural MRI studies have found associations between 
temporal regions and both hallucinations 
4,45
 and thought disorder 
46
. While frontal associations 
with the positive subscale have been observed less frequently in the literature, several other 
studies have found correlations between the positive subscale and reductions in overall frontal 
volume 
47
 or GMV in regions such as the inferior frontal gyrus 
48,49
. Abnormalities in frontal 
regions could impact cognitive processes of working memory, attention, and language processing 
50
, contributing to positive symptoms such as disorganization and delusions.  
Comparing diagnostic groups, structure-symptom correlations were larger in the 
schizophrenia group than in the two other diagnostic categories. However, our factor analysis did 
not find significant interactions between diagnosis and structural factors on symptom subscales, 
indicating no major impact of diagnosis on structure-symptom correlations. Overall, findings in 
the schizophrenia group may reflect their higher level of subtle brain pathology, which may in 
turn be associated with their more chronic and persistent psychotic symptoms compared with 
schizoaffective and bipolar I disorders. Differences in exposure to antipsychotic medication are 
unlikely to completely account for the larger effect sizes of correlations in schizophrenia. While 
individuals with schizophrenia typically have greater exposure to antipsychotics than individuals 
with bipolar disorder, our secondary analyses found that antipsychotic medication dose did not 
have a major impact on effect sizes of correlations.  
The PANSS negative subscale correlated inversely with CSA of right frontal regions, and 
factor analysis identified a frontal GMV-SA factor among those regions that correlated with the 
negative subscale. These results corroborate prior studies reporting correlations between frontal 
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reductions and negative symptoms 
13,51-53
, and inverse correlations between regional cerebral 
blood flow and negative symptoms on positron emission tomography (PET) scans 
54
. Overall, the 
negative subscale demonstrated fewer correlations with structural measures than the positive 
subscale. This observation may indicate the relatively greater contribution of social and non-
structural biological influences in the manifestation of negative symptoms. 
As predicted, CT and CSA diverged in their associations with symptom subscales. CT 
reductions exhibited more correlations with symptom subscales, particularly the positive 
subscale, than CSA. Interestingly, one recent trans-diagnostic study of schizophrenia and bipolar 
I found more widespread regional reductions in CT than in CSA 
20
. This study (and an earlier 
study with the same subject sample) did not find associations of either type of structural measure 
with symptom subscales 
20,22
.  Our findings suggest that CT may be more closely associated with 
symptoms of psychosis than CSA. These findings may reflect the distinct neurobiological 
processes underlying these two aspects of structure. As mentioned earlier, recent research 
indicates that CT and CSA may have distinct genetic influences 
28
, may follow independent 
developmental trajectories in childhood 
27
, and may not be highly correlated with each other 
20
. 
CT has been shown to fluctuate in response to environmental factors such as cannabis use 
55,56
 
and childhood trauma 
56
, and may represent a “state” marker that tracks more closely with 
fluctuating positive symptoms than CSA. Given the more widespread correlations of CT with the 
symptom dimensions, particularly the positive subscale, future investigations may wish to focus 
on pathophysiological processes of CT as driving the development of psychosis.  
Notably, while correlations were significant, their magnitudes were small, indicating that 
other factors likely make independent contributions to symptom severity. Symptom severity is 
partly driven by social factors, such as education and socioeconomic status, whose 
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neurobiological effects may not be captured by structural measures. Additionally, small effect 
sizes of structure-symptom correlations may complement the findings of neuropathology studies 
of schizophrenia, which observe subtle reductions in cortical neuropil and volumes of neuronal 
cell bodies, rather than loss of neurons 
57,58
. The effect sizes of our correlations may also reflect 
the influence of processes that enlarge structural measures. For example, inflammation, which 
may be important in early stages of schizophrenia 
59
, could lead to structural enlargement 
through free water retention, thus reducing the strength of inverse correlations between structure 
and symptoms. Overall, the small effect sizes of structure-symptom correlations corroborate the 
concept of psychosis as a disorder of network connectivity 
60
, involving subtle neurochemical 
and neurophysiological alterations in the interactions between brain regions. Our observations of 
frontal and temporal contributions to psychosis is consistent with the possibility that fronto-
temporal connectivity may be of particular importance in the pathogenesis of positive symptoms 
61
. 
This study had several strengths. This is one of the largest sample sizes thus far in which 
this question has been examined. Inclusion of all three diagnostic categories permitted the 
examination of associations in psychosis in a trans-diagnostic fashion, and inclusion of CT and 
CSA permitted exploration of their relative associations with symptom subscales. Many potential 
confounding factors were included in the analysis. Additionally, the subject sample consisted of 
clinically stable, chronically ill individuals. Structural and physiological abnormalities may 
change across the course of illness in psychosis 
62
, and structural alterations may be more 
relevant in understanding persistent symptoms in a chronic population. Thus, our results may 
reflect more stable correlations between brain structure and residual, treatment-resistant 
psychopathology.  
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There were several limitations. Because data were cross-sectional, it was not possible to 
draw conclusions about causal relationships. The region-of-interest analysis necessitated a heavy 
correction for multiple comparisons, which may have obscured some findings. Additionally, data 
on subjects’ lifetime history of antipsychotic use were not collected, although current 
antipsychotic use was included. Longitudinal antipsychotic use may be associated with gray 
matter changes 
63
 and may have contributed to structure-symptom correlations in this study. Last, 
neuropsychological test results were not analyzed here, though they have been reported 
elsewhere in this sample 
64
. 
In conclusion, among a combined group of individuals with schizophrenia, 
schizoaffective, and bipolar I disorders, the PANSS positive subscale was inversely correlated 
with GMV and cortical thickness in frontal and temporal regions, while the PANSS negative 
subscale was inversely correlated with frontal cortical surface area and GMV. Overall, cortical 
thickness appeared more strongly associated with psychopathology, particularly the positive 
subscale, than cortical surface area. However, the magnitudes of all correlations were low. These 
results lend support to associations between structural brain alterations and severity of 
psychopathology. 
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Table 1. Subject Demographics and Symptom Scale Characteristics        
  All Patients Schizophrenia Schizoaffective Bipolar I 
n 455 181 117 157 
Mean Age (sd) 36.2 (12.7) 35.8 (12.6) 36.0 (12.1) 36.7 (13.3) 
Sex M : F 
a 
(% M : % F) 
220 : 235 
48% : 52% 
118 : 63 
65% : 35% 
56 : 61 
48% : 52% 
46 : 111 
29% : 71% 
Race (%)
a,b 
AA: 184 (40 %) 
CA: 242 (53 %) 
OT: 29 (6 %) 
AA: 94 (52 %) 
CA: 73 (40 %) 
OT: 14 (8 %) 
AA: 52 (44 %) 
CA: 58 (50 %) 
OT: 7 (6 %) 
AA: 38 (24 %) 
CA: 111 (71 %) 
OT: 8 (5 %) 
Mean PANSS Positive (sd)
c
 16.2 (5.5) 17.2 (5.4) 18.6 (4.9) 13.3 (4.8) 
Mean PANSS Negative (sd)
c 
14.9 (5.3) 16.8 (5.8) 15.4 (4.5) 12.3 (4.1) 
Mean PANSS General (sd)
c 
32.2 (9.0) 32.8 (9.1) 35.0 (8.7) 29.5 (8.4) 
Mean PANSS Total (sd)
c 
63.3 (16.9) 66.7 (16.9) 69.1 (15.4) 55.1 (14.7) 
Mean Intracranial Volume (sd)
c 
1437 cc (186 cc) 1467 cc (197 cc) 1396 cc (177 cc) 1434 cc (174 cc) 
Mean Duration of Illness (sd)
c 
18.6 yrs (12.3 yrs) 16.4 yrs (11.8 yrs) 19.9 yrs (11.7 yrs) 20.1 yrs (12.9 yrs) 
Mean Years of Education (sd)
c 
13.4 yrs (2.4 yrs) 12.8 yrs (2.3 yrs) 13.2 yrs (2.2 yrs) 14.3 yrs (2.4 yrs) 
Mean Hollingshead Score (sd)
c,d 
48.2 (15.7) 53.2 (14.6) 48.7 (14.6) 42.1 (15.7) 
Antipsychotic Status (%)
a,e 
Yes: 85%; No: 15% Yes: 92%; No:8% Yes: 86%; No: 14% Yes: 75%; No: 25% 
a
significantly different across diagnostic groups by chi-squared test 
b
AA = African-American; CA = Caucasian-American; OT = Other 
c
significantly different across diagnostic groups by Kruskal-Wallis test 
d
Hollingshead occupation score multiplied by 7, added to Hollingshead education score multiplied by 4; higher score indicates lower social class 
e
currently taking antipsychotics (yes or no) 
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Table 2. Structure-Subscale Correlations Within Combined Group and Within Diagnostic Categories 
   Combined Group Schizophrenia Schizoaffective Bipolar I 
Lobe Measurement Subscale r p-adjusted
a 
r p-value
b 
r p-value
b 
r p-value
b 
Left Frontal GMV 
GMV 
PANSS 
Positive 
-0.162 0.016 -0.176 0.018 -0.072 0.44 -0.067 0.41 
Left pars orbitalis -0.182 0.004 -0.113 0.130 -0.139 0.13 -0.141 0.078 
Left superior frontal -0.166 0.013 -0.170 0.022 -0.170 0.067 -0.015 0.85 
Right Frontal GMV 
GMV 
PANSS 
Positive 
-0.165 0.013 -0.170 0.022 -0.015 0.88 -0.031 0.70 
Right superior frontal -0.180 0.005 -0.160 0.032 -0.155 0.095 0.010 0.90 
Right Temporal GMV 
GMV 
PANSS 
Positive 
-0.158 0.020 -0.141 0.058 -0.054 0.57 -0.020 0.80 
Right superior temporal -0.155 0.031 -0.155 0.036 -0.148 0.11 -0.020 0.80 
Right fusiform -0.178 0.005 -0.089 0.240 -0.145 0.12 -0.067 0.40 
Right Temporal CT 
Cortical 
Thickness 
PANSS 
Positive 
-0.173 0.007 -0.183 0.013 -0.079 0.40 -0.047 0.56 
Right middle temporal -0.150 0.045 -0.199 0.0072 0.025 0.79 -0.091 0.26 
Right superior temporal -0.155 0.032 -0.138 0.064 -0.102 0.27 -0.104 0.19 
Right insula -0.175 0.006 -0.236 0.0014
c -0.075 0.42 0.021 0.80 
Right Frontal Area 
Surface Area 
PANSS 
Negative 
-0.151 0.041 -0.153 0.040 0.081 0.34 -0.023 0.77 
Right pars orbitalis -0.138 0.026 -0.145 0.051 -0.150 0.11 -0.093 0.25 
Right superior frontal -0.138 0.026 -0.101 0.17 0.016 0.86 -0.190 0.018 
Right precentral -0.159 0.007 -0.150 0.043 -0.064 0.49 -0.162 0.042 
a 
p-values Hochberg-adjusted as described in the text 
b 
unadjusted p-value  
c
 significant after Hochberg correction 
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Table 3. Factor Analysis: Regions Loading Above 0.45 on Factors Derived Through Principal Factors Extraction 
Positive Subscale: Four Factors Negative Subscale: One Factor 
F1: Temporal CT F2: Frontal GMV F3: Fronto-parietal CT F4: Precuneus F: Frontal GMV-SA 
L fusiform CT 
R middle temporal CT 
R superior temporal CT 
R fusiform CT 
L inferior temporal CT 
R inferior temporal CT 
R insula CT 
L fusiform GMV 
L insula CT 
R temporal pole CT 
R banks of superior 
temporal sulcus CT 
R fusiform GMV 
R middle temporal GMV 
R lateral orbitofrontal GMV 
R superior frontal GMV 
L lateral orbitofrontal GMV 
L superior frontal GMV 
R superior frontal CSA 
R rostral middle frontal GMV 
L superior frontal CSA 
L pars orbitalis GMV 
R pars orbitalis GMV 
L rostral middle frontal GMV 
L superior parietal CT 
R inferior parietal CT 
L superior frontal CT 
R lateral occipital CT 
R supramarginal CT 
R superior frontal CT 
L lateral occipital CT 
L supramarginal CT 
L superior parietal GMV 
R lingual CT 
R precuneus GMV 
L precuneus GMV 
R precuneus CSA 
R fusiform CSA 
R superior frontal GMV 
R superior frontal CSA 
R precentral GMV 
R precentral CSA 
R lateral orbitofrontal CSA 
R pars orbitalis CSA 
R pars orbitalis GMV 
R paracentral CSA 
L superior parietal GMV 
L posterior cingulate GMV 
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Figure 1. Significant correlations between lobe measures and positive symptom severity for all patients and diagnostic groups; plotted values are 
residuals after adjustment for co-variates.  
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Figure 1. Significant correlations between lobe measures and positive symptom severity for all patients and 
diagnostic groups; plotted values are residuals after adjustment for co-variates.  
103x56mm (300 x 300 DPI)  
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Supplemental Table 1: Component sub-regions of lobes 
Lobes (Right and Left) Component sub-regions of lobe (identical for right and left lobes) 
Frontal GMV GMV of caudal middle frontal, rostral middle frontal, medial orbitofrontal, lateral orbitofrontal, pars opercularis, pars 
orbitalis, pars triangularis, superior frontal, precentral, and paracentral regions 
Temporal GMV GMV of banks superior temporal sulcus, inferior temporal, middle temporal, superior temporal, fusiform, entorhinal, 
parahippocampal, transverse temporal, temporal pole, and insula regions 
Limbic GMV GMV of hippocampus, amygdala, caudal anterior cingulate, isthmus cingulate, rostral anterior cingulate, posterior 
cingulate 
Striatal GMV GMV of thalamus, caudate, putamen, pallidum, and accumbens  
Parietal GMV GMV of inferior parietal, superior parietal, supramarginal, precuneus, and postcentral regions 
Occipital GMV GMV of cuneus, lingual, pericalcarine, and lateral occipital regions 
Frontal Surface Area Identical to Frontal GMV, but composed of surface areas 
Temporal Surface Area Identical to Temporal GMV, but composed of surface areas 
Limbic Surface Area Surface areas of caudal anterior cingulate, isthmus cingulate, rostral anterior cingulate, and posterior cingulate regions 
Parietal Surface Area Identical to Parietal GMV, but composed of surface areas 
Occipital Surface Area Identical to Occipital GMV, but composed of surface areas 
Frontal Cortical Thickness Identical to Frontal GMV, but composed of cortical thicknesses 
Temporal Cortical Thickness Identical to Temporal GMV, but composed of cortical thicknesses 
Limbic Cortical Thickness Cortical thicknesses of caudal anterior cingulate, isthmus cingulate, rostral anterior cingulate, posterior cingulate 
Parietal Cortical Thickness Identical to Parietal GMV, but composed of cortical thicknesses 
Occipital Cortical Thickness Identical to Occipital GMV, but composed of cortical thicknesses 
Notes: 1. Component sub-regions were identical for lobes within both hemisphere. 2. Striatal regions are sub-cortical; thus, cortical thickness and 
surface area measurements were unavailable for these regions. 
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Supplemental Table 2. Study Site Differences 
Site 1 (CT) 2 (GP) 3 (GT) 4 (JS) 5 (MB) 6 (MK) 
Location Texas Connecticut Maryland Illinois Boston Detroit 
N 85 46 114 120 24 66 
Mean PANSS 
Positive (sd) 
19.0 (4.3) 15.7 (4.6) 14.6 (5.9) 16.2 (5.4) 13.0 (5.5) 17.0 (5.4) 
Mean PANSS 
Negative (sd) 
15.1 (3.9) 14.6 (5.7) 14.1 (5.1) 16.1 (6.1) 12.3 (6.3) 14.9 (4.8) 
Mean PANSS 
General (sd) 
36.7 (7.7) 32.5 (8.5) 26.0 (6.7) 33.9 (8.5) 28.3 (10.2) 35.4 (8.7) 
Mean PANSS 
Total (sd) 
70.8 (14.4) 62.8 (15.8) 54.7 (14.2) 66.2 (16.5) 53.6 (19.7) 67.3 (17.2) 
 
Within-site 
Diagnostic 
Breakdown 
(N, %) 
SP: 21 (25 %) 
SZA: 38 (45 %) 
BP: 26 (31 %) 
SP: 16 (35 %) 
SZA: 20 (43 %) 
BP: 10 (22 %) 
SP: 64 (56 %) 
SZA: 23 (20 %) 
BP: 27 (24 %) 
SP: 37 (31 %) 
SZA: 27 (23 %) 
BP: 56 (47 %) 
SP: 8 (33 %) 
SZA: 3 (13 %) 
BP: 13 (54 %) 
SP: 35 (53 %) 
SZA: 6 (9 %) 
BP: 25 (38 %) 
Notes: 1. SP = schizophrenia, SZA = schizoaffective disorder, BP = bipolar I with psychotic features. Percentages may not add up to 100 due to 
rounding. 2. Subscale scores were significantly different across sites (p < 0.05 by Kruskal-Wallis test). 
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60
Supplemental Table 3. Factor Loadings for Principal Factors Extraction and Oblique Rotation of Four Factors: 
Positive Subscale 
 F1: Temporal 
CT 
F2: Frontal 
GMV 
F3: Fronto-
parietal CT 
F4: Precuneus 
SS Loadings 8.00 6.70 6.67 3.96 
Proportion of Variance 0.14 0.12 0.12 0.07 
L fusiform CT 0.82    
R middle temporal CT 0.81    
R superior temporal CT 0.79    
R fusiform CT 0.73    
L inferior temporal CT 0.71    
R inferior temporal CT 0.69    
R insula CT 0.58    
L fusiform GMV 0.55    
L insula CT 0.55    
R temporal pole CT 0.55    
R banks of superior temporal sulcus CT 0.50    
R fusiform GMV 0.47    
R middle temporal GMV 0.46    
R lateral orbitofrontal GMV  0.75   
R superior frontal GMV  0.70   
L lateral orbitofrontal GMV  0.66   
L superior frontal GMV  0.61   
R superior frontal CSA  0.57   
R rostral middle frontal GMV  0.57   
L superior frontal CSA  0.56   
L pars orbitalis GMV  0.52   
R pars orbitalis GMV  0.50   
L rostral middle frontal GMV  0.49   
L superior parietal CT   0.83  
R inferior parietal CT   0.81  
L superior frontal CT   0.81  
R lateral occipital CT   0.70  
R supramarginal CT   0.67  
R superior frontal CT   0.59  
L lateral occipital CT   0.52  
L supramarginal CT   0.51  
L superior parietal GMV   0.51  
Right lingual CT   0.46  
R precuneus GMV    0.67 
L precuneus GMV    0.61 
R precuneus CSA    0.60 
R fusiform CSA    0.50 
There were no cross-loadings.  The following regions did not load above 0.45 on any factor: L caudal middle 
frontal GMV, L isthmus cingulate GMV, L superior temporal GMV, L hippocampus GMV, R hippocampus 
GMV, R pars triangularis GMV, R supramarginal GMV, R banks of superior temporal sulcus GMV, R superior 
temporal GMV,  L lateral occipital GMV, L superior temporal CSA, L pars orbitalis CSA, L transverse temporal 
CSA, L caudal middle frontal CSA, L pars triangularis CSA, L posterior cingulate CT, L parahippocampal CT, R 
posterior cingulate CT, R pars triangularis CT, L medial orbitofrontal CT, L pars orbitalis CT.   
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 Supplemental Table 4. Factor Loadings for Principal Factors 
Extraction of One Factor: Negative Subscale 
 Frontal GMV-SA factor 
SS Loading 3.54 
Proportion of Variance 0.25 
R superior frontal GMV 0.72 
R superior frontal CSA 0.71 
R precentral GMV 0.66 
R precentral CSA 0.62 
R lateral orbitofrontal CSA 0.60 
R pars orbitalis CSA 0.51 
R pars orbitalis GMV 0.48 
R paracentral CSA 0.46 
L superior parietal GMV 0.45 
L posterior cingulate GMV 0.44 
Regions not loading above 0.45 on this factor: R fusiform CSA, 
R fusiform GMV, R posterior cingulate CT, R fusiform CT 
 
 
Supplemental Figure 1: Correlations between regional brain structure and positive and negative symptom 
subscales. 
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Supplemental Figure 1. Correlations between regional brain structure and positive and negative symptom 
subscales.  
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